Ask AI

The Evolving and Transformative Role of Maintenance Therapy in the First-line Setting of HER2+ Metastatic Breast Cancer

Enhance your understanding of maintenance therapy for HER2+ MBC to individualize treatment plans and improve patient outcomes based on the latest clinical evidence and advancements through a certified on-demand webcast, expert-authored ClinicalThought commentary, certified case challenges, downloadable resources and slides, and a podcast.

Share

Program Content

Activities

ND HER2+ MCB Patient Checklist
Newly Diagnosed HER2+ Metastatic Breast Cancer: Patient–Provider Communication Checklist
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: October 23, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer, Inc.